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Background: Drug hypersensitivity is defined as any unfavorable reaction that occurs after the administration of any drug. It may 
or may not be mediated by the involvement of the immune system. Epidemiological data related to drug hypersensitivity reactions 
in our country are scarce.
Objective: To determine the prevalence of drug hypersensitivity in a group of young adults, as well as to identify associated 
factors.
Methods: A structured questionnaire was applied to young people aged 18 to 25 years. The instrument was oriented to identify 
reactions of drug hypersensitivity, as well as the most prevalent drugs involved. In addition, a personal and family history of atopic 
diseases was included. Analysis for associations between variables was been done through logistic regression.
Results: The prevalence of drug hypersensitivity reactions was 12% (144 of 1,200). The antibiotics were the agents most related 
to hypersensitivity reactions (9.8%) followed by nonsteroidal anti-inflammatory drugs (1.6%). Factors associated with drug 
hypersensitivity were a personal history of asthma, odds ratio (OR) 3.15 (95% confidence interval [CI], 1.44–6.91), maternal and 
paternal history of drug hypersensitivity, OR 2.33 (95% CI, 1.21–4.48) and OR 3.11 (95% CI, 1.22–7.92), respectively.
Conclusion: The results of this research show that drug hypersensitivity in young adults is a highly prevalent event and it is 
associated with personal history of asthma and history of drug hypersensitivity in parents.
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INTRODUCTION
Drug hypersensitivity is defined as those unfavorable reactions 
that occur after the administration of any drug. It may or may 
not be mediated by the involvement of the immune system 
[1]. Determining its prevalence in the population represents a 
real challenge, since the majority of the research related to this 
problem, have been carried out in the hospital environment. 
Results from previous studies, obtained through questionnaires, 
show that drug hypersensitivity range from 5% to 25% of the 
population studied [2-7].
Health problems related to the use of drugs are considered 
as a dynamic process, they depend on the treatment protocols, 
new products, as well as new pharmacological indications [8]. 
However, there are 2 groups of drugs that over the years appear 
to have not changed their prevalence, β-lactam antibiotics and 
nonsteroidal anti-inflammatory drugs (NSAIDs) [2, 5-11].
Factors causing drug hypersensitivity reactions have been 
classified depending on drug physicochemical characteristics, 
the treatment protocol and the patient itself [12]. Among patient 
characteristics are sex, age, comorbidities and history of drug 
reactions [2, 5, 6, 11, 13, 14].
Data related to drug hypersensitivity in our country is scarce, 
and especially in population studies. Thus, the objective of this 
study was to determine the prevalence of drug hypersensitivity 
in Mexican young adults. In addition, to associate personal and 
family history of atopic diseases with drug hypersensitivity. 
MATERIALS AND METHODS
Design and subjects
This study is a secondary analysis of a previous research [15]. 
A cross-sectional study, carried out between February and May 
2014, analyzed a sample of 1,200 students from a public university 
(State of Mexico), aged 18 to 25. A nonprobabilistic sampling was 
performed.
Questionnaire
A structured questionnaire was applied to investigate the 
personal and family history of allergic diseases: asthma, allergic 
rhinitis, urticaria, atopic dermatitis, and drug hypersensitivity [15].
Conventionally, drug hypersensitivity was determined by the 
following question: “Are you allergic to any drug?” [2, 4-6]. If the 
answer was affirmative, the type of drug involved in the reaction 
and the types of reactions were questioned.
Statistical analysis
The prevalence of drug hypersensitivity was calculated by 
dividing the affirmative response frequency by the total number 
of respondents. The odds ratio (OR) assessed the magnitude of 
the association between personal or family history of allergic 
disease with drug hypersensitivity. In all cases, 95% confidence 
intervals (CIs) were estimated. Risks were adjusted through binary 
logistic regression analysis. Values of p ≤ 0.05 were considered 
statistically significant. The data collected were analyzed with 
SPSS Statistics version 22.0 (IBM Co., Armonk, NY, USA).
Ethical consideration
This research was approved by the Ethics and Research 
Committee of the Center for Research in Medical Sciences of the 
Autonomous University of the State of Mexico (approval number: 
2014/05). Students signed a written informed consent. 
RESULTS
The frequency of drug hypersensitivity was 144 of 1,200 with 
a prevalence of 12%. The prevalence in women was 13.4% and 
in men 10.0%, however, there was not statistically different (p 
= 0.068). Students in the Faculty of Chemistry had the highest 
prevalence, 15.4% (46 of 298); then Faculty of Dentistry, 11.9% (16 
of 135) and Medicine, 11.8% (61 of 517). The lowest frequency was 
found in the Faculty of Engineering, 8.4% (21 of 250); however, no 
significant difference was observed among groups (p = 0.093).
The mean age of subjects with drug hypersensitivity did 
not differ significantly from those without reactions (p = 0.240) 
(Table 1). Personal clinical history of asthma was more frequent 
in students with drug hypersensitivity (p = 0.001). In addition, 
maternal clinical history of atopic dermatitis (p = 0.018) and drug 
hypersensitivity (p = 0.001), as well as a paternal clinical history 
of drug hypersensitivity (p = 0.004), were significantly related to 
drug hypersensitivity in students.
Antibiotics (9.8%), then NSAIDs (1.6%) and antihistamines 
(0.4%) were the most common category of drugs (Table 2). 
Penicillin was the most common antibiotic (6.3%), followed by 
sulfonamides (1.8%) and then cephalosporin (0.4%) (Table 3). 
Among the NSAIDs, acetylsalicylic acid (0.7%) was the most 
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prevalent, followed by naproxen (0.5%) and metamizole (0.2%). 
Unexpectedly, among antihistamines, loratadine caused 0.4% of 
hypersensitivity reactions.
The multivariate analysis identified the personal clinical history 
of asthma (OR, 3.15; p = 0.004), and maternal or paternal clinical 
history of drug hypersensitivity (OR, 2.33; p = 0.011 and OR, 3.11; 
p = 0.018, respectively) as well as factors associated with drug 
hypersensitivity (Table 4).
Additionally univariate analyzes showed that personal clinical 
history of asthma was associated with hypersensitivity to 
antibiotics (OR, 2.69; 95% CI, 1.14–6.37; p = 0.024) and also did 
with NSAIDs (OR, 4.51; 95% CI, 0.99–20.41; p = 0.05). Among the 
antibiotics, the sulfonamides showed a significant association 
with the clinical history of asthma (OR, 9.13; 95% CI, 2.90–28.72; p 
= 0.0002). In contrast, among the NSAIDs
Ibuprofen was related to personal history of asthma (OR, 111.28; 
95% CI, 4.44–2,785.75; p = 0.0004) but not acetylsalicylic acid (OR, 
2.10; 95% CI, 0.12–37.17; p = 0.612).
DISCUSSION
In this study, the prevalence of drug hypersensitivity was 12% 
Table 1. Clinical characteristics of the study group (n = 1,200)
Characteristic 
Drug hypersensitivity
p-value
Yes (n =144) No (n =1,056)
Age (yr) 19.5 ± 1.7 19.7 ± 1.7 0.240
Sex
Male 50 (34.7) 451 (42.7) 0.068
Female 94 (65.3) 605 (57.3)
Personal clinical history of allergic disease
Asthma 10 (6.9) 22 (2.1) 0.001
Allergic rhinitis 25 (17.4) 159 (15.1) 0.472
Atopic dermatitis 10 (6.9) 58 (5.5) 0.480
Parental clinical history of allergic disease
Mother
Asthma 2 (1.4) 21 (2.0) 0.999
Allergic rhinitis 10 (6.9) 57 (5.4) 0.448
Atopic dermatitis 7 (4.9) 19 (1.8) 0.018
Drug hypersensitivity 14 (9.7) 40 (3.8) 0.001
Father
Asthma 1 (0.7) 4 (0.4) 0.473
Allergic rhinitis 4 (2.8) 34 (3.2) 0.776
Atopic dermatitis 0 (0) 5 (0.5) 0.999
Drug hypersensitivity 7 (4.9) 15 (1.4) 0.004
Values are presented as mean ± standard deviation or number (%).
p-value obtained by the Student t-test, chi-square test or Fisher exact test. 
p ≤ 0.05 was considered statistically significant.
Table 2. Prevalence of drug hypersensitivity according to drug category in 
young adults (n =1,200)
Drug category Number (%)
Antibiotics 117 (9.8)
NSAIDs 19 (1.6)
Antihistamines 5 (0.4)
Mucolytic 1 (0.1)
Antivirals 1 (0.1)
Bronchodilators 1 (0.1)
NSAIDs, nonsteroidal anti-inflammatory drugs.  
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in university students. Thus, this is the first report of prevalence 
of drug hypersensitivity in our country in young adults. Mainly 
β-lactams and acetylsalicylic acid were the most prevalent drugs 
as the cause of hypersensitivity reactions. Factors associated with 
drug hypersensitivity were the personal clinical history of asthma 
and the paternal or maternal history of drug hypersensitivity.
At the global level, efforts to determine the prevalence of 
drug hypersensitivity in general population are scarce. Studies 
conducted in university students have shown that the problems 
associated with drug hypersensitivity are a common event. For 
example in Turkey, a group of medical students had a prevalence 
of drug hypersensitivity of 4.7% [2]. Recently in the United Arab 
Emirates, a group of students showed a drug hypersensitivity 
frequency of 7% [3]. Interestingly, our findings are quite similar 
to those reported for a population of university students in 
Brazil (12.1%) [4]. On the other hand, it was found that in an adult 
population of Portugal, the frequency was 7.8% [5], while in 
Turkey, the number of subjects who self-reported some type of 
drug reaction was 13.4% [6]. In Maputo, Africa 25% of a studied 
population reported drug hypersensitivity [7]. In hospitalized 
patients, the prevalence of drug hypersensitivity is higher than in 
the general population. For example, a survey study in patients 
who were to undergo surgery reported allergic drug reactions 
(up to more than 38%) [9]. In another study, performed in an 
Emergency Department, 13% of the patients declared to be 
allergic to some type of antibiotic [16]. 
Drugs that have been mostly related to hypersensitivity 
reactions are antibiotics or NSAIDs. In our study, students with 
drug hypersensitivity reported more than 80% reactions due to 
the use of antibiotics, mainly β-lactams and less than 15% were 
related to the use of NSAIDs. These findings are similar to previous 
reports [2, 5-7, 9-11]. However, there are also studies in which 
NSAIDs are most prevalently associated with hypersensitivity 
reactions [4, 17, 18]. Perhaps for our country, the high prevalence 
of antibiotics compared with NSAIDs is a consequence of the 
lack of regulation in the sale of antibiotics that began until 2010 
[19]. It allowed the general population to be overexposed to 
them (self-medication), thus in this way facilitated the process of 
sensitization.
In our study, the drugs that were most closely related to 
hypersensitivity reactions were penicillin, then sulfonamides 
and acetylsalicylic acid. This is consistent with the findings 
of previous studies [2, 9]. Interestingly, there were 5 students 
who self-perceived as “allergic” to loratadine. Antihistamines 
are a group of medications widely used in the control of the 
symptoms of allergy and other diseases, however, few occasions 
produce hypersensitivity reactions. In Spain, a study reported 
five cases of urticaria associated with an antihistamine treatment 
[20]. It has also been reported a case of levocetirizine-induced 
fixed drug eruption [21], associated with piperazine derivatives 
and another one of urticaria by hydroxyzine and cetirizine [22]; 
also, anaphylactic reactions have also been documented [23, 
24]. The questionnaire did not inquire about the symptoms 
caused by drugs, therefore it could be hard to tell drug allergy 
or hypersensitivity from other side effects, especially in cases of 
ambroxol, amantadine, or salbutamol which showed a low 
prevalence. In this study, no hypersensitivity events due to 
Table 3. Prevalence of drug hypersensitivity in young adults (n = 1,200)
Drug hypersensitivity Number (%)
Antibiotics 
Penicillin 76 (6.3)
Sulfonamide 22 (1.8)
Cephalosporin 5 (0. 4)
Ampicillin 4 (0.3)
Erythromycin 3 (0.3)
Amoxicillin 3 (0.3)
Trimethoprim 2 (0.2)
Tetracycline 1 (0.1)
Ciprofloxacin 1 (0.1)
NSAIDs
Acetylsalicylic acid 8 (0.7)
Naproxen 6 (0.5)
Metamizole 2 (0.2)
Ketorolaco 1 (0.1)
Paracetamol 1 (0.1)
Ibuprofen 1 (0.1)
Antihistamines 
Loratadine 5 (0.4)
Mucolytic
Ambroxol 1 (0.1)
Antivirals
Amantadine 1 (0.1)
Bronchodilators
Salbutamol 1 (0.1)
NSAIDs, nonsteroidal anti-inflammatory drugs.
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anesthetics, muscle relaxants or image contrast medium were 
reported.
Several factors associated with drug hypersensitivity have been 
described, some of which are related to drug itself, others with 
the treatment protocol and others with the participant [12]. In our 
study, we focused on factors related to the subjects and in their 
parental clinical history of drug hypersensitivity. This relationship 
has been documented previously; for example, Alergológica-2005, 
a multicenter study carried out in Spain, reported that patients 
with a family history of drug allergy were more likely to be allergic 
to some medication [11]. Similarly, Bavbek et al. [2]  showed that 
the family history of drug hypersensitivity was associated with a 
higher probability of drug reactions in 2 self-reported studies, 1 
with medical students and other studies in the open population 
[2, 6]. Similar findings were observed in factory workers in Turkey 
[13] where the personal history of allergic disease was associated 
with drug hypersensitivity [2, 6, 11, 13]. In our study, we observed 
that family history of asthma showed this association.
It is suggested that genetic predisposition, sex, and age play an 
important role in the development of drug hypersensitivity [5, 6, 
11, 13, 14]. In this study, the genetic predisposition was suspected 
through the parental clinical history of drug hypersensitivity. 
Our results show that sulfonamides were related to the personal 
clinical history of asthma, this type of association has rarely 
been reported, since the manifestations triggered by this group 
of drugs affect the skin [25]. A possible explanation would be 
that these students had a possible anaphylactic reaction as a 
manifestation of allergy to sulfonamides.
On the other hand, ibuprofen hypersensitivity was also 
associated with asthma. Traditionally acetylsalicylic acid, a COX-
1 inhibitor, has been associated with this type of problem, 
producing aspirin-exacerbated respiratory disease. Ibuprofen 
inhibits COX-1 just like acetylsalicylic acid, thus producing 
bronchospasm [26, 27]. The association could be due to people 
uses ibuprofen more frequently than acetylsalicylic acid.
One of the main limitations of our study was that the 
diagnosis of drug hypersensitivity was through a self-reported 
questionnaire, which implies the possibility that the subject 
has misinterpreted some unrelated symptoms as part of drug 
allergy. Another limitation was the use of the term allergy 
instead of hypersensitivity to detect drug reactions. Finally, we 
did not specifically question the discomfort derived from drug 
Table 4. Multivariate models of factors associated with drug hypersensitivity in young adults
Variable
Not-adjusted model Adjusted model
OR 95% CI p-value OR 95% CI p-value
Sex 
Men 1
Women 1.37 0.94–1.98 0.098 - - 0.092
Personal clinical history of asthma
No 1 1
Yes 3.14 1.42–6.93 0.005 3.15 1.44–6.91 0.004
Maternal clinical history of atopic dermatitis 
No 1
Yes 2.17 0.85–5.57 0.105 - - 0.093
Maternal clinical history of drug hypersensitivity 
No 1 1
Yes 2.10 1.07–4.09 0.030 2.33 1.21–4.48 0.011
Paternal clinical history of drug hypersensitivity
No 1 1
Yes 2.99 1.15–7.82 0.025 3.11 1.22–7.92 0.018
OR, odds ratio; CI, confidence interval.
OR of the variables that served as fit are not shown in the adjusted model.
p ≤ 0.05 was considered statistically significant.
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hypersensitivity neither corroborated the diagnosis. Even so, this 
study provided an opportunity to estimate the size of reactions 
associated with drug use.
In conclusion, the perceived prevalence of drug hypersensitivity 
among university students is high. On the other hand, the personal 
clinical history of asthma and the parental clinical history of drug 
hypersensitivity are factors associated with drug hypersensitivity.
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